BIM23B065

BIM23B065 · Ipsen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIM23B065, covering 2019-03-08 to 2019-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly [Phase 2]